Multiple Sclerosis and neuroimmunology research

We are deeply committed to clinical and laboratory research. As a world leader, we are engaged in numerous clinical trials investigating the effect of various new treatments targeting not only the disease process but also its symptomatology.

An important part of our clinical research is our image-processing and OCT laboratories; one of the few in the country. Following the tradition established by our late Chair and director, Dr. Omar Khan, our research focuses on the use of novel MRI technology for early disease detection and to better understand the demyelinating pathology and promote new therapeutic approaches. Our goal is to achieve neuro repair and neuroprotection, minimize the disabling effect of the disease and contribute to a better quality of life for individuals living with MS.  Explore our research at the MR Core Research Facility at https://mrc.wayne.edu/ and our team  https://mrc.wayne.edu/faculty

The Neuroimaging and Neurorehabilitation Laboratory (NNL) is a foundational component of our Multiple Sclerosis and Neuroimmunology Research program by advancing rehabilitation-focused neuroscience through state‑of‑the‑art imaging and quantitative assessment tools. The lab develops innovative strategies to address both motor and cognitive decline in individuals with neurodegenerative diseases (e.g., multiple sclerosis) by integrating structural neuroimaging, functional measures, and novel rehabilitation paradigms. Its work enhances our understanding of how motor and cognitive systems interact, enabling the design of targeted interventions that support recovery, promote neuroplasticity, and improve overall functional outcomes for people living with MS.

Our research has been funded by the National Institute of Health, National MS Society, the Sastry Family Foundation and pharmaceutical companies.  Click here to view current clinical trials